This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2010 Dec:16 Suppl 1:S1-11.

doi: 10.1002/ibd.21529.

Clinical scenarios in IBD: optimizing the use of conventional and biologic agents

Stephen B Hanauer, Asher A Kornbluth, Julie Messick, David T Rubin, William J Sandborn, Bruce E Sands

PMID: 21104734
DOI: 10.1002/ibd.21529

Review

Clinical scenarios in IBD: optimizing the use of conventional and biologic agents

Stephen B Hanauer et al. Inflamm Bowel Dis. 2010 Dec.

. 2010 Dec:16 Suppl 1:S1-11.

doi: 10.1002/ibd.21529.

Authors

Stephen B Hanauer, Asher A Kornbluth, Julie Messick, David T Rubin, William J Sandborn, Bruce E Sands

PMID: 21104734
DOI: 10.1002/ibd.21529

No abstract available

PubMed Disclaimer

Similar articles

Optimizing biologic treatment in IBD: objective measures, but when, how and how often?
Ben-Horin S, Mao R, Chen M. Ben-Horin S, et al. BMC Gastroenterol. 2015 Dec 18;15:178. doi: 10.1186/s12876-015-0408-x. BMC Gastroenterol. 2015. PMID: 26678147 Free PMC article. Review.
Heading back to the trough (levels of biologics in IBD).
Hanauer SB. Hanauer SB. Clin Gastroenterol Hepatol. 2015 Mar;13(3):548-51. doi: 10.1016/j.cgh.2014.10.007. Epub 2014 Oct 13. Clin Gastroenterol Hepatol. 2015. PMID: 25311382 Review. No abstract available.
Medical Therapy for Inflammatory Bowel Disease.
Grevenitis P, Thomas A, Lodhia N. Grevenitis P, et al. Surg Clin North Am. 2015 Dec;95(6):1159-82, vi. doi: 10.1016/j.suc.2015.08.004. Epub 2015 Oct 23. Surg Clin North Am. 2015. PMID: 26596920 Review.
New and emerging biologics in the treatment of inflammatory bowel disease: quo vadis?
Danese S, Angelucci E. Danese S, et al. Gastroenterol Clin Biol. 2009 Jun;33 Suppl 3:S217-27. doi: 10.1016/S0399-8320(09)73157-4. Gastroenterol Clin Biol. 2009. PMID: 20117345 Review.
Advances in the use of biologics and other novel drugs for managing inflammatory bowel disease.
Park SH, Aniwan S, Loftus EV Jr. Park SH, et al. Curr Opin Pharmacol. 2017 Dec;37:65-71. doi: 10.1016/j.coph.2017.09.007. Epub 2017 Oct 6. Curr Opin Pharmacol. 2017. PMID: 28992449 Review.

See all similar articles

Cited by

Clinical utility of newly developed immunoassays for serum concentrations of adalimumab and anti-adalimumab antibodies in patients with Crohn's disease.
Imaeda H, Takahashi K, Fujimoto T, Bamba S, Tsujikawa T, Sasaki M, Fujiyama Y, Andoh A. Imaeda H, et al. J Gastroenterol. 2014 Jan;49(1):100-9. doi: 10.1007/s00535-013-0803-4. Epub 2013 Apr 11. J Gastroenterol. 2014. PMID: 23575576
The colonic interleukin-19 aggravates the dextran sodium sulfate/stress-induced comorbidities due to colitis and anxiety.
Li Q, Meng F, Ma X, Sun Z, Dai J, Liu J, Li D, Cong P, Xu R, Zhao D, Wang W, Wang D, Liu C, Wang F, Li C, Lian H. Li Q, et al. Front Immunol. 2023 Mar 2;14:1153344. doi: 10.3389/fimmu.2023.1153344. eCollection 2023. Front Immunol. 2023. PMID: 36936941 Free PMC article.
Use of ghrelin as a treatment for inflammatory bowel disease: mechanistic considerations.
Deboer MD. Deboer MD. Int J Pept. 2011;2011:189242. doi: 10.1155/2011/189242. Epub 2011 Aug 9. Int J Pept. 2011. PMID: 21845198 Free PMC article.
TNF blocking therapies and immunomonitoring in patients with inflammatory bowel disease.
Altwegg R, Vincent T. Altwegg R, et al. Mediators Inflamm. 2014;2014:172821. doi: 10.1155/2014/172821. Epub 2014 Mar 18. Mediators Inflamm. 2014. PMID: 24757282 Free PMC article. Review.
An Assessment of the AGA and CCFA Quality Indicators in a Sample of Patients Diagnosed with Inflammatory Bowel Disease.
Tkacz J, Brady BL, Meyer R, Lofland JH, Ruetsch C, Coelho-Prabhu N. Tkacz J, et al. J Manag Care Spec Pharm. 2015 Nov;21(11):1064-76. doi: 10.18553/jmcp.2015.21.11.1064. J Manag Care Spec Pharm. 2015. PMID: 26521118 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.